Paul Travers

4.9k total citations · 1 hit paper
108 papers, 3.7k citations indexed

About

Paul Travers is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Travers has authored 108 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 18 papers in Molecular Biology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Travers's work include Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (24 papers). Paul Travers is often cited by papers focused on Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (24 papers). Paul Travers collaborates with scholars based in United Kingdom, United States and France. Paul Travers's co-authors include Mark Walport, Charles A. Janeway, Mark J. Shlomchik, Nicholas R. J. Gascoigne, S. Munir Alam, Stephen C. Jameson, Walter F. Bodmer, Stella Redpath, J. Alejandro Madrigal and John Trowsdale and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Paul Travers

105 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T-cell-receptor affinity and thymocyte positive selection

1996 537 citations S. Munir Alam, Paul Travers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Travers United Kingdom	29	2.1k	819	549	454	297	108	3.7k
Peter J. Wettstein United States	34	1.8k 0.8×	1.3k 1.6×	346 0.6×	429 0.9×	238 0.8×	137	4.1k
Hiroyuki Kishi Japan	36	2.8k 1.3×	1.4k 1.7×	611 1.1×	1.1k 2.5×	307 1.0×	181	5.2k
P.E.J. van Erp Netherlands	37	1.9k 0.9×	990 1.2×	287 0.5×	635 1.4×	626 2.1×	214	4.9k
Ryuji Suzuki Japan	35	2.1k 1.0×	929 1.1×	278 0.5×	984 2.2×	321 1.1×	160	4.9k
M R Shalaby United States	27	2.0k 0.9×	1.7k 2.1×	722 1.3×	805 1.8×	514 1.7×	45	4.7k
P. C. Wilkinson United Kingdom	36	1.6k 0.8×	1.2k 1.4×	285 0.5×	643 1.4×	278 0.9×	118	3.9k
Virna Cortez‐Retamozo United States	17	2.0k 0.9×	1.4k 1.8×	654 1.2×	794 1.7×	352 1.2×	24	4.2k
Patrice N. Marche France	42	2.2k 1.0×	1.9k 2.4×	439 0.8×	470 1.0×	762 2.6×	227	5.7k
Frank A. Robey United States	37	1.4k 0.7×	2.1k 2.6×	736 1.3×	470 1.0×	465 1.6×	71	5.1k
George F. Murphy United States	37	2.2k 1.0×	561 0.7×	267 0.5×	578 1.3×	481 1.6×	65	4.5k

Countries citing papers authored by Paul Travers

Since Specialization

Citations

This map shows the geographic impact of Paul Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Travers more than expected).

Fields of papers citing papers by Paul Travers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Travers. The network helps show where Paul Travers may publish in the future.

Co-authorship network of co-authors of Paul Travers

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Travers. A scholar is included among the top collaborators of Paul Travers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Travers. Paul Travers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Travers, Paul, et al.. (2022). HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells. 11(8). 1339–1339. 4 indexed citations

Senegaglia, Alexandra Cristina, Roberto H. Herai, Cármen Lúcia Kuniyoshi Rebelatto, et al.. (2020). The Expression Profile of Dental Pulp-Derived Stromal Cells Supports Their Limited Capacity to Differentiate into Adipogenic Cells. International Journal of Molecular Sciences. 21(8). 2753–2753. 20 indexed citations

Batsivari, Antoniana, Stanislav Rybtsov, Céline Souilhol, et al.. (2017). Understanding Hematopoietic Stem Cell Development through Functional Correlation of Their Proliferative Status with the Intra-aortic Cluster Architecture. Stem Cell Reports. 8(6). 1549–1562. 48 indexed citations

Cameron, Kate, Paul Travers, C. L. Chander, et al.. (2012). Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate. Journal of Biomedical Materials Research Part A. 101A(1). 13–22. 35 indexed citations

Lefranc, Marie‐Paule, Ann‐Margaret Little, Sarah Grace, et al.. (2011). Cytomegalovirus‐specific CD8⁺T cells targeting different peptide/HLA combinations demonstrate varying T‐cell receptor diversity. Immunology. 135(1). 27–39. 8 indexed citations

Knight, Andrea, J. Alejandro Madrigal, Sarah Grace, et al.. (2010). The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. 116(12). 2164–2172. 159 indexed citations

Rusakiewicz, Sylvie, J. Alejandro Madrigal, Paul Travers, & Anthony I. Dodi. (2009). BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donors. Cancer Immunology Immunotherapy. 58(9). 1449–1457. 13 indexed citations

Halling‐Brown, Mark, Ruby Quartey‐Papafio, Paul Travers, & D. S. Moss. (2006). SiPep: a system for the prediction of tissue‐specific minor histocompatibility antigens. International Journal of Immunogenetics. 33(4). 289–295. 11 indexed citations

Rosette, Caridad, Guy Werlen, Mark A. Daniëls, et al.. (2001). The Impact of Duration versus Extent of TCR Occupancy on T Cell Activation. Immunity. 15(1). 59–70. 202 indexed citations

10.

Janeway, Charles A., Paul Travers, Mark Walport, & Mark J. Shlomchik. (2001). Adaptive Immunity to Infection. 26(10). 1626–34. 8 indexed citations

11.

Janeway, Charles A., Paul Travers, Mark Walport, & Mark J. Shlomchik. (2001). The interaction of the antibody molecule with specific antigen. 133(6). 946–8. 14 indexed citations

12.

Janeway, Charles A., Paul Travers, Mark Walport, & Mark J. Shlomchik. (2001). The rearrangement of antigen-receptor gene segments controls lymphocyte development. The Science of The Total Environment. 235(1-3). 101–9.

13.

Gascoigne, Nicholas R. J., S. Munir Alam, Shane Marine, et al.. (2000). T Cell Receptor Binding Kinetics and Special Role of Vα in T Cell Development and Activation. Immunologic Research. 21(2-3). 225–232. 7 indexed citations

14.

Noort, Johannes M. van, David Baker, Arianne C. van Sechel, et al.. (2000). Encephalitogenic and immunogenic potential of the stress protein αB-crystallin in Biozzi ABH (H-2Ag7) mice. Journal of Neuroimmunology. 104(1). 47–57. 32 indexed citations

15.

Bartnes, Kristian, Francisco León, Jean‐Paul Briand, Paul Travers, & Kristian Hannestad. (1999). N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively. European Journal of Immunology. 29(1). 189–195. 16 indexed citations

16.

Alam, S. Munir, G. Davies, Tomasz Żal, et al.. (1999). Qualitative and Quantitative Differences in T Cell Receptor Binding of Agonist and Antagonist Ligands. Immunity. 10(2). 227–237. 183 indexed citations

17.

Sim, Bee-Cheng, Paul Travers, & Nicholas R. J. Gascoigne. (1997). V alpha 3.2 selection in MHC class I mutant mice: evidence for an alternate orientation of TCR-MHC class I interaction. The Journal of Immunology. 159(7). 3322–3329. 13 indexed citations

18.

Jurčević, Stipo, et al.. (1996). Distinct conformations of a peptide bound to HLA-DR1 or DRB5^*0101 suggested by molecular modelling. International Immunology. 8(11). 1807–1814. 17 indexed citations

19.

Travers, Paul, et al.. (1992). II for T, and T4 too. Current Biology. 2(1). 38–40. 2 indexed citations

20.

Blundell, T.L., Stephen P. Gardner, Tim Hubbard, et al.. (1989). Protein engineering and design. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 324(1224). 447–460. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact